Berobenatide
A Study to Learn About Safety and Effects of Once-weekly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JW)
Pfizer · Phase 3 · Recruiting · Enrollment 180
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Treatment Arm 2 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Placebo | Obesity or overweight | n/r | n/r | n/r | n/r |
| Treatment Arm 3 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Treatment Arm 1 | Obesity or overweight | n/r | n/r | n/r | n/r |